Showing results (141-150 of 723) with videos related to
Sort By:
Pageof 73
Plos One|March 27, 2014
Cancer specific mortality in insulin-treated type 2 diabetes patientsSorin Ioacara, Cristian Guja, Constantin Ionescu-Tirgoviste, et al.Acta Diabetologica|June 6, 2014
Oxidative stress predicts progression of peripheral and cardiac autonomic nerve dysfunction over 6 years in diabetic patientsDan Ziegler, Stefanie Buchholz, Christoph Sohr, et al.Nutrition Research (New York, N.Y.)|June 12, 2014
Validity and reproducibility of an interviewer-administered food frequency questionnaire in Austrian adults at risk of or with overt diabetes mellitusMichaela Farukuoye, Klaus Strassburger, Gertrud Kacerovsky-Bielesz, et al.Digestive Diseases (Basel, Switzerland)|April 29, 2011
MnSOD overexpression prevents liver mitochondrial DNA depletion after an alcohol binge but worsens this effect after prolonged alcohol consumption in miceAbdellah Mansouri, Arige Tarhuni, Isabelle Larosche, et al.Trends in Endocrinology and Metabolism: TEM|September 28, 2022
NAFLD and thyroid function: pathophysiological and therapeutic considerationsErifili Hatziagelaki, Stavroula A Paschou, Martin Schön, et al.Current Diabetes Reports|October 25, 2017
Cardiorespiratory Fitness and Cardiac Autonomic Function in DiabetesMartin Röhling, Alexander Strom, Gidon J Bönhof, et al.BMC Bioinformatics|July 11, 2024
A strategy to detect metabolic changes induced by exposure to chemicals from large sets of condition-specific metabolic models computed with enumeration techniquesLouison Fresnais, Olivier Perin, Anne Riu, et al.Cancer Research|March 7, 2019
Retrodifferentiation of Human Tumor Hepatocytes to Stem Cells Leads to Metabolic Reprogramming and ChemoresistanceKarim Fekir, Hélène Dubois-Pot-Schneider, Romain Désert, et al.Diabetes Care|July 14, 2009
Transforming growth factor-beta1 and incident type 2 diabetes: results from the MONICA/KORA case-cohort study, 1984-2002Christian Herder, Astrid Zierer, Wolfgang Koenig, et al.Diabetes, Obesity & Metabolism|June 22, 2026
Glucagon-Like Peptide-1 Receptor Agonists and Incident Major Adverse Liver Outcomes in People With Type 2 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver DiseaseGregor A Maier, Ramon A Hofmann, Michael Roden, et al.Pageof 73